Rapid Therapeutic Science Lab inc
Rapid Therapeutic Science Laboratories, Inc. focuses on developing potential commercial opportunities which involve the rapid application of therapeutics using inhaler technology. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013… Read more
Rapid Therapeutic Science Lab inc (RTSL) - Total Assets
Latest total assets as of December 2024: $967.76K USD
Based on the latest financial reports, Rapid Therapeutic Science Lab inc (RTSL) holds total assets worth $967.76K USD as of December 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Rapid Therapeutic Science Lab inc - Total Assets Trend (2012–2024)
This chart illustrates how Rapid Therapeutic Science Lab inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Rapid Therapeutic Science Lab inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Rapid Therapeutic Science Lab inc's total assets of $967.76K consist of 18.1% current assets and 81.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $175.05K | 18.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2012–2024)
This chart illustrates how Rapid Therapeutic Science Lab inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Rapid Therapeutic Science Lab inc's current assets represent 18.1% of total assets in 2024, a decrease from 100.0% in 2012.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 76.2% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 18.1% of total assets.
Rapid Therapeutic Science Lab inc Competitors by Total Assets
Key competitors of Rapid Therapeutic Science Lab inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
464680
KQ:464680
|
Korea | ₩31.23 Billion |
|
Cartesian Growth Corporation III Unit
NASDAQ:CGCTU
|
USA | $281.56 Million |
|
Azure Holding Group Corp
PINK:AZRH
|
USA | $16.92 Million |
|
Constellation Capital Corp.
V:CNST-P
|
Canada | CA$627.53K |
|
Little Fish Acquisition I Corp.
V:LILL-P
|
Canada | CA$56.48K |
|
Hana 30 Special Purpose Acquisition Company
KQ:469880
|
Korea | ₩17.89 Billion |
|
Chicane Capital I Corp.
V:CCIC-P
|
Canada | CA$199.07K |
|
Cuspis Capital II Ltd
V:CCII-P
|
Canada | CA$1.51 Million |
Rapid Therapeutic Science Lab inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Rapid Therapeutic Science Lab inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Rapid Therapeutic Science Lab inc is currently not profitable relative to its asset base.
Rapid Therapeutic Science Lab inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.04 | 0.05 | 0.10 |
| Quick Ratio | 0.00 | 0.01 | 0.10 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-3.88 Million | $ -4.67 Million | $ -1.09 Million |
Rapid Therapeutic Science Lab inc - Advanced Valuation Insights
This section examines the relationship between Rapid Therapeutic Science Lab inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 136.70 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | -57.1% |
| Total Assets | $967.76K |
| Market Capitalization | $65.11K USD |
Valuation Analysis
Below Book Valuation: The market values Rapid Therapeutic Science Lab inc's assets below their book value (0.07 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Rapid Therapeutic Science Lab inc's assets decreased by 57.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Rapid Therapeutic Science Lab inc (2012–2024)
The table below shows the annual total assets of Rapid Therapeutic Science Lab inc from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $967.76K | -57.08% |
| 2022-12-31 | $2.25 Million | +2.48% |
| 2021-12-31 | $2.20 Million | +394.83% |
| 2019-12-31 | $444.59K | +1594.18% |
| 2018-12-31 | $26.24K | 0.00% |
| 2018-03-31 | $26.24K | +254.86% |
| 2017-12-31 | $7.39K | -25.96% |
| 2016-03-31 | $9.99K | 0.00% |
| 2015-12-31 | $9.99K | -56.64% |
| 2014-12-31 | $23.03K | -45.15% |
| 2012-12-31 | $41.99K | -- |